Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

A systematic review of cost-sharing strategies used within publicly-funded drug plans in member countries of the organisation for economic co-operation and development.

Barnieh L, Clement F, Harris A, Blom M, Donaldson C, Klarenbach S, Husereau D, Lorenzetti D, Manns B.

PLoS One. 2014 Mar 11;9(3):e90434. doi: 10.1371/journal.pone.0090434. eCollection 2014.

PMID:
24618721
[PubMed - in process]
Free PMC Article
2.

A synthesis of drug reimbursement decision-making processes in organisation for economic co-operation and development countries.

Barnieh L, Manns B, Harris A, Blom M, Donaldson C, Klarenbach S, Husereau D, Lorenzetti D, Clement F.

Value Health. 2014 Jan-Feb;17(1):98-108. doi: 10.1016/j.jval.2013.10.008.

PMID:
24438723
[PubMed - indexed for MEDLINE]
3.

Relationship of the use and costs of physician office visits and prescription drugs to travel distance and increases in member cost share.

Cecil WT, Barnes J, Shea T, Coulter SL.

J Manag Care Pharm. 2006 Oct;12(8):665-76.

PMID:
17269845
[PubMed - indexed for MEDLINE]
Free Article
4.

Pharmaceutical policies: effects of cap and co-payment on rational drug use.

Austvoll-Dahlgren A, Aaserud M, Vist G, Ramsay C, Oxman AD, Sturm H, Kösters JP, Vernby A.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD007017. doi: 10.1002/14651858.CD007017. Review.

PMID:
18254125
[PubMed - indexed for MEDLINE]
5.

Association between drug insurance cost sharing strategies and outcomes in patients with chronic diseases: a systematic review.

Mann BS, Barnieh L, Tang K, Campbell DJ, Clement F, Hemmelgarn B, Tonelli M, Lorenzetti D, Manns BJ.

PLoS One. 2014 Mar 25;9(3):e89168. doi: 10.1371/journal.pone.0089168. eCollection 2014. Review.

PMID:
24667163
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Comparison of provincial prescription drug plans and the impact on patients' annual drug expenditures.

Demers V, Melo M, Jackevicius C, Cox J, Kalavrouziotis D, Rinfret S, Humphries KH, Johansen H, Tu JV, Pilote L.

CMAJ. 2008 Feb 12;178(4):405-9. doi: 10.1503/cmaj.070587.

PMID:
18268266
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

An early examination of access to select orphan drugs treating rare diseases in health insurance exchange plans.

Robinson SW, Brantley K, Liow C, Teagarden JR.

J Manag Care Pharm. 2014 Oct;20(10):997-1004.

PMID:
25278322
[PubMed - in process]
Free Article
8.

Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies.

Acosta A, Ciapponi A, Aaserud M, Vietto V, Austvoll-Dahlgren A, Kösters JP, Vacca C, Machado M, Diaz Ayala DH, Oxman AD.

Cochrane Database Syst Rev. 2014 Oct 16;10:CD005979. doi: 10.1002/14651858.CD005979.pub2. Review.

PMID:
25318966
[PubMed - indexed for MEDLINE]
9.

Spending on medicines in Israel in an international context.

Sax P.

Isr Med Assoc J. 2005 May;7(5):286-91.

PMID:
15909459
[PubMed - indexed for MEDLINE]
Free Article
10.

Prescription drugs: issues of cost, coverage, and quality.

Copeland C.

EBRI Issue Brief. 1999 Apr;(208):1-21.

PMID:
10539445
[PubMed - indexed for MEDLINE]
11.

Making a case for employing a societal perspective in the evaluation of Medicaid prescription drug interventions.

Roy S, Madhavan SS.

Pharmacoeconomics. 2008;26(4):281-96. Review.

PMID:
18370564
[PubMed - indexed for MEDLINE]
12.

Impact of multitiered copayments on the use and cost of prescription drugs among Medicare beneficiaries.

Gilman BH, Kautter J.

Health Serv Res. 2008 Apr;43(2):478-95. doi: 10.1111/j.1475-6773.2007.00774.x.

PMID:
18370964
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Impact of cost sharing on prescription drugs used by Medicare beneficiaries.

Goedken AM, Urmie JM, Farris KB, Doucette WR.

Res Social Adm Pharm. 2010 Jun;6(2):100-9. doi: 10.1016/j.sapharm.2010.03.003. Epub 2010 May 7.

PMID:
20511109
[PubMed - indexed for MEDLINE]
14.

The impact of cost sharing of prescription drug expenditures on health care utilization by the elderly: own- and cross-price elasticities.

Li X, Guh D, Lacaille D, Esdaile J, Anis AH.

Health Policy. 2007 Aug;82(3):340-7. Epub 2006 Nov 28.

PMID:
17134787
[PubMed - indexed for MEDLINE]
15.

Approaches to pharmacy benefit management and the impact of consumer cost sharing.

Olson BM.

Clin Ther. 2003 Jan;25(1):250-72. Review.

PMID:
12637125
[PubMed - indexed for MEDLINE]
16.

A bitter pill: formulary variability and the challenge to prescribing physicians.

Shrank WH, Ettner SL, Glassman P, Asch SM.

J Am Board Fam Pract. 2004 Nov-Dec;17(6):401-7.

PMID:
15575031
[PubMed - indexed for MEDLINE]
Free Article
17.

European healthcare policies for controlling drug expenditure.

Ess SM, Schneeweiss S, Szucs TD.

Pharmacoeconomics. 2003;21(2):89-103.

PMID:
12515571
[PubMed - indexed for MEDLINE]
18.

Comparison of mail-order with community pharmacy in plan sponsor cost and member cost in two large pharmacy benefit plans.

Johnsrud M, Lawson KA, Shepherd MD.

J Manag Care Pharm. 2007 Mar;13(2):122-34.

PMID:
17330973
[PubMed - indexed for MEDLINE]
Free Article
19.

Prescription cost sharing: economic and health impacts, and implications for health policy.

Levy RA.

Pharmacoeconomics. 1992 Sep;2(3):219-37.

PMID:
10147012
[PubMed - indexed for MEDLINE]
20.

Prescription drug cost sharing: associations with medication and medical utilization and spending and health.

Goldman DP, Joyce GF, Zheng Y.

JAMA. 2007 Jul 4;298(1):61-9. Review.

PMID:
17609491
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk